The Pennant Group, Inc.
PNTGNASDAQHealthcareMedical Care Facilities
As of Oct 23, 2026 close
- Market cap
- $1.51B
- P/E (TTM)
- 46.59
- Forward P/E
- 38.61
- Dividend yield
- -
- 52-week range
- $22.26$42.74
- Volume (live)
- -
- Avg. volume (3M)
- 376.31K
The Pennant Group (PNTG) Stock Price & Financial Analysis
The Pennant Group Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $41.73 - $42.25 |
|---|---|
| 52-Week High | $42.74 |
| 52-Week Low | $22.26 |
| Open | $41.78 |
| Volume (last close) | 233.32K |
| Average Volume (3M) | 376.31K |
| Revenue (TTM) | 1.10B |
|---|---|
| Net Income (TTM) | 32.32M |
| Free Cash Flow (TTM) | 25.99M |
| EPS (TTM) | $0.91 |
| Profit Margin | 2.93% |
| Operating Margin | 5.77% |
| Return on Equity (ROE) | 7.99% |
| Debt to Equity | 0.49 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.51B |
|---|---|
| Shares Outstanding | 35.96M |
| P/E Ratio (TTM) | 46.59 |
| Forward P/E | 38.61 |
| Price to Sales (P/S) | 1.37 |
| Price to Book (P/B) | 3.72 |
| EV/EBITDA | 26.04 |
| 50-Day MA | $39.47 |
|---|---|
| 200-Day MA | $34.91 |
| 1-Year Change | +72.51% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
The Pennant Group at a Glance
As of the Oct 23, 2026 close, The Pennant Group (PNTG) has a market capitalization of $1.51B. The stock trades at 46.6× trailing earnings, 38.6× forward earnings and 1.4× sales. Over the trailing twelve months it earned $32.32M on revenue of $1.10B (a 2.9% profit margin) and generated $25.99M of free cash flow. Revenue grew 37.9% year over year.
As of its latest reported balance sheet, it holds $15.27M in cash and securities against $197.50M of debt, a net debt position of $182.23M.
The Pennant Group does not currently pay a dividend.
The share price is up 72.5% over the past year. At $41.88 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $22.25 to $42.74, above its 200-day moving average of $34.91.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $46.00, 9.8% above the Oct 23, 2026 close.
Frequently Asked Questions About The Pennant Group
What is the current stock price for PNTG?
As of the Oct 23, 2026 close, PNTG stock trades at $41.88. The 52-week range is $22.26–$42.74, with a day range of $41.73–$42.25.
What is the P/E ratio for PNTG?
As of the Oct 23, 2026 close, The Pennant Group's trailing twelve-month (TTM) P/E ratio is 46.6, meaning investors pay $46.6 for every $1 of annual earnings. The forward P/E is 38.6, reflecting analyst expectations for future earnings. The Pennant Group operates in the Healthcare sector.
Does PNTG pay dividends?
The Pennant Group does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for PNTG?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for PNTG is Buy. The average 12-month price target is $46.00, a 9.8% upside from the Oct 23, 2026 close of $41.88.
What is the market cap of PNTG?
As of the Oct 23, 2026 close, The Pennant Group's market capitalization is $1.51B, classifying it as a small-cap company. The Pennant Group operates in the Healthcare sector within the Medical Care Facilities industry.